ENDOtollins: New Drug Reduces Inflammation Without Compromising Immunity
Researchers have developed ENDOtollins, a novel drug designed to reduce systemic inflammation in patients with autoimmune diseases. By targeting specific inflammatory pathways, this biotechnology aims to prevent tissue damage and ... Read More